Introduction: Adjustable intragastric balloon (aIGB), as known as a novel minimally invasive therapy for obesity, provide a sustained alternative for weight loss. Weight loss is achieved by implanting
Objective: Endogenous subclinical hyperthyroidism (eSCH) is defined by subnormal serum thyroid-stimulating hormone (TSH) level. There is limited evidence of metabolic changes induced by eSCH. The aim
ABSTRACT - BACKGROUND: Obesity is a disease characterized by an excessive accumulation of body fat, which is harmful to health, and it has grown significantly in the past years in the majority of cou